d ala2 gip Search Results


d ala2 gip  (Tocris)
91
Tocris d ala2 gip
D Ala2 Gip, supplied by Tocris, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+ala2+gip/pm37442376-107-15-16?v=Tocris
Average 91 stars, based on 1 article reviews
d ala2 gip - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier
long-acting gip analogue d-ala2-gip  (Pepceuticals Ltd)
90
Pepceuticals Ltd long-acting gip analogue d-ala2-gip
Intraperitoneal administration of <t>GIP</t> increases lymph fluid and TG output from the gut during post-absorptive state. (A) Lymph flow rate, (B) TG concentration and (C) TG output during the experiment, and (D) Total Lymph Volume and Total TG Output during the first hour. Data are mean ± SEM. n = 7 each group. * p < 0.05, ** p < 0.01, *** p < 0.001 GIP <t>vs.</t> <t>PBS.</t>
Long Acting Gip Analogue D Ala2 Gip, supplied by Pepceuticals Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+ala2+gip/pmc12006050-60-19-28?v=Pepceuticals+Ltd
Average 90 stars, based on 1 article reviews
long-acting gip analogue d-ala2-gip - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
d-ala2-gip  (GL Biochem)
90
GL Biochem d-ala2-gip
Intraperitoneal administration of <t>GIP</t> increases lymph fluid and TG output from the gut during post-absorptive state. (A) Lymph flow rate, (B) TG concentration and (C) TG output during the experiment, and (D) Total Lymph Volume and Total TG Output during the first hour. Data are mean ± SEM. n = 7 each group. * p < 0.05, ** p < 0.01, *** p < 0.001 GIP <t>vs.</t> <t>PBS.</t>
D Ala2 Gip, supplied by GL Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+ala2+gip/pm35712239-59-0-12?v=GL+Biochem
Average 90 stars, based on 1 article reviews
d-ala2-gip - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
mouse d ala2 gip  (Novo Nordisk)
86
Novo Nordisk mouse d ala2 gip
Intraperitoneal administration of <t>GIP</t> increases lymph fluid and TG output from the gut during post-absorptive state. (A) Lymph flow rate, (B) TG concentration and (C) TG output during the experiment, and (D) Total Lymph Volume and Total TG Output during the first hour. Data are mean ± SEM. n = 7 each group. * p < 0.05, ** p < 0.01, *** p < 0.001 GIP <t>vs.</t> <t>PBS.</t>
Mouse D Ala2 Gip, supplied by Novo Nordisk, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+ala2+gip/pmc12448133-187-0-3?v=Novo+Nordisk
Average 86 stars, based on 1 article reviews
mouse d ala2 gip - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
selective gip receptor agonist d-ala 2 gip  (USV Limited)
90
USV Limited selective gip receptor agonist d-ala 2 gip
Intraperitoneal administration of <t>GIP</t> increases lymph fluid and TG output from the gut during post-absorptive state. (A) Lymph flow rate, (B) TG concentration and (C) TG output during the experiment, and (D) Total Lymph Volume and Total TG Output during the first hour. Data are mean ± SEM. n = 7 each group. * p < 0.05, ** p < 0.01, *** p < 0.001 GIP <t>vs.</t> <t>PBS.</t>
Selective Gip Receptor Agonist D Ala 2 Gip, supplied by USV Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+ala2+gip/pm29577894-45-4-20?v=USV+Limited
Average 90 stars, based on 1 article reviews
selective gip receptor agonist d-ala 2 gip - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
d-ala 2 gip  (Lupin Laboratories Inc)
90
Lupin Laboratories Inc d-ala 2 gip
Intraperitoneal administration of <t>GIP</t> increases lymph fluid and TG output from the gut during post-absorptive state. (A) Lymph flow rate, (B) TG concentration and (C) TG output during the experiment, and (D) Total Lymph Volume and Total TG Output during the first hour. Data are mean ± SEM. n = 7 each group. * p < 0.05, ** p < 0.01, *** p < 0.001 GIP <t>vs.</t> <t>PBS.</t>
D Ala 2 Gip, supplied by Lupin Laboratories Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+ala2+gip/pm29577894-17-1-30?v=Lupin+Laboratories+Inc
Average 90 stars, based on 1 article reviews
d-ala 2 gip - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
d ala2 gip  (Phoenix Pharmaceuticals)
86
Phoenix Pharmaceuticals d ala2 gip
Intraperitoneal administration of <t>GIP</t> increases lymph fluid and TG output from the gut during post-absorptive state. (A) Lymph flow rate, (B) TG concentration and (C) TG output during the experiment, and (D) Total Lymph Volume and Total TG Output during the first hour. Data are mean ± SEM. n = 7 each group. * p < 0.05, ** p < 0.01, *** p < 0.001 GIP <t>vs.</t> <t>PBS.</t>
D Ala2 Gip, supplied by Phoenix Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+ala2+gip/pmc12352888-200-3-7?v=Phoenix+Pharmaceuticals
Average 86 stars, based on 1 article reviews
d ala2 gip - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
[d-ala2]-gip  (MedChemExpress)
N/A
[D-Ala2]-GIP (human) is a GIP receptor agonist. [D-Ala2]-GIP (human) improves glucose tolerance. [D-Ala2]-GIP (human) shows neuroprotective activity in MPTP-induced Parkinson's disease model. [D-Ala2]-GIP (human) also improves cognitive function and hippocampal synaptic plasticity in obese diabetic
   Buy from Supplier
[d-ala2]-gip  (TargetMol)
N/A
   Buy from Supplier

Image Search Results


Intraperitoneal administration of GIP increases lymph fluid and TG output from the gut during post-absorptive state. (A) Lymph flow rate, (B) TG concentration and (C) TG output during the experiment, and (D) Total Lymph Volume and Total TG Output during the first hour. Data are mean ± SEM. n = 7 each group. * p < 0.05, ** p < 0.01, *** p < 0.001 GIP vs. PBS.

Journal: Frontiers in Physiology

Article Title: Glucose-dependent insulinotropic polypeptide stimulates post-absorptive lipid secretion in the intestine

doi: 10.3389/fphys.2025.1549392

Figure Lengend Snippet: Intraperitoneal administration of GIP increases lymph fluid and TG output from the gut during post-absorptive state. (A) Lymph flow rate, (B) TG concentration and (C) TG output during the experiment, and (D) Total Lymph Volume and Total TG Output during the first hour. Data are mean ± SEM. n = 7 each group. * p < 0.05, ** p < 0.01, *** p < 0.001 GIP vs. PBS.

Article Snippet: 5 h later, rats (n = 7–8 per group) were randomized to receive intraperitoneal infusion of either a long-acting GIP analogue (D-Ala2-GIP, 0.12 mg/kg, in 1 mL PBS; Pepceuticals Ltd., Leicestershire, UK) or placebo (PBS, 1 mL).

Techniques: Concentration Assay

Intraperitoneal administration of GIP increases apolipoprotein B48 output from the gut during post-absorptive state. (A) Lymph ApoB48 concentration and (B) lymph apoB48 output during the experiment. Data are mean ± SEM. n = 7 each group. * p < 0.05, ** p < 0.01 GIP vs. PBS.

Journal: Frontiers in Physiology

Article Title: Glucose-dependent insulinotropic polypeptide stimulates post-absorptive lipid secretion in the intestine

doi: 10.3389/fphys.2025.1549392

Figure Lengend Snippet: Intraperitoneal administration of GIP increases apolipoprotein B48 output from the gut during post-absorptive state. (A) Lymph ApoB48 concentration and (B) lymph apoB48 output during the experiment. Data are mean ± SEM. n = 7 each group. * p < 0.05, ** p < 0.01 GIP vs. PBS.

Article Snippet: 5 h later, rats (n = 7–8 per group) were randomized to receive intraperitoneal infusion of either a long-acting GIP analogue (D-Ala2-GIP, 0.12 mg/kg, in 1 mL PBS; Pepceuticals Ltd., Leicestershire, UK) or placebo (PBS, 1 mL).

Techniques: Concentration Assay